Research Associate-I Position in NIAB, Hyderabad, Telangana, India -

TcpB-Derived Peptide Innovation at BRIC-National Institute of Animal Biotechnology- NIAB Under the Department of Biotechnology, India-supported hashtag#BioE3 Policy, researchers BRIC–NIAB have engineered TcpB-derived peptide TB4-BBL2 from Brucella protein to combat inflammation and infection. The peptide lowers inflammatory cytokines by over 70% and enhances bacterial clearance 100-fold in mice — paving the way for next-gen anti-inflammatory and sepsis therapies. #Immunotherapy #PeptideTherapy #

Researchers at BRIC-National Institute of Animal Biotechnology- NIAB and Manipal Academy of Higher Education have studied a novel potential regulatory role of splicing factor Cdc5 in maintaining transcriptome integrity imperative for toxoplasma’s survival in the host. They have shown that inhibiting TgCdc5 abolishes splicing, causes dysregulated gene expression and impedes various parasite processes. Mice infected with parasites produce a strong immune response when TgCdc5 is depleted, shielding

#BioE3Pakhwada Startup Showcase #9 bioLOCKEY Healthworks, a spin-off from Institute for Stem Cell Science and Regenerative Medicine and incubated at Centre for Cellular and Molecular Platforms, India, is pioneering nanobody-based smart diagnostics with a strong focus on women’s health — making rapid, self-use tests safer, affordable, and more accessible. The startup is building next-gen point-of-care solutions, including cervical cancer and HPV screening, preterm birth detection, and Alzheimer’s

Hyderabad NIAB director's jewellery worth Rs 50 lakh stolen from Gurugram hotel

11 reactions | Catch a glimpse of our Swachhata Pakhwada 2025 Awardee BRIC-National Institute of Animal Biotechnology- NIAB on various #Swachhata events at their campus. Dr Jitendra Singh BRIC DBT - Department of Biotechnology CSIR NISCPR-Oғғɪᴄɪᴀʟ Pᴀɢᴇ | Department of Biotechnology, India | Facebook